Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06194461 · ClinicalTrials.gov registry record
LTFU for All Cell and Gene Therapy Studies
A clinical trial, sponsored by AstraZeneca.
- Not yet
- Registry status
- 64
- Enrollment target
NCT06194461 is a clinical trial that has not yet begun recruiting, run by AstraZeneca. The registered enrollment target is 64 participants.
The verdict
NCT06194461 has not yet begun recruiting, sponsored by AstraZeneca.
- NOT YET RECRUITING
- Registry status
- 64 participants
- Enrollment target
Study Summary
Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.
Interventions
- BIOLOGICAL AZD0754
- BIOLOGICAL AZD5851
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-09-17 |
| Est. Completion | 2041-11-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06194461
The ClinicalTrials.gov registry entry for NCT06194461 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AZD0754 is the first listed.
NCT06194461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06194461 about?
NCT06194461 is a clinical study titled "LTFU for All Cell and Gene Therapy Studies". Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.
What is the current status of trial NCT06194461?
This trial is currently not yet recruiting. The enrollment target is 64 participants. The study started on 2025-09-17. Estimated completion is 2041-11-29.
What interventions are being tested in trial NCT06194461?
The interventions under investigation include: AZD0754 (BIOLOGICAL), AZD5851 (BIOLOGICAL).
Who is sponsoring clinical trial NCT06194461?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.